Date/Time
Date(s) - 16 Nov 2026
1:00 PM - 2:00 PM
Behind the Investment: How Xcellerant Ventures Evaluates Opportunities
Online event
What makes a promising startup worth investing in? And how do you look beyond a compelling pitch to evaluate a company’s potential?
Join Chris Yoo and Mike Shufeldt of Xcellerant Ventures for a behind-the-scenes look at how our team sources, evaluates, and selects companies for investment.
With experience spanning entrepreneurship, aerospace, biotechnology, and emerging technologies, Chris and Mike will share how Xcellerant Ventures approaches investment due diligence, assesses opportunities, and evaluates the factors that can distinguish a promising company from a compelling investment opportunity.
In this webinar, you’ll learn:
- What we look for: The qualities, characteristics, and market dynamics that make a company worth considering for investment.
- Beyond the pitch deck: How we evaluate founding teams, technology, market opportunity, competitive positioning, and business potential.
- Red flags and risks: Key questions we ask and potential challenges we investigate during due diligence.
- From evaluation to investment: How our team weighs opportunities and determines which companies may be a fit for the Jetstream Venture Fund portfolio.
Whether you’re an investor interested in venture capital, a healthcare or technology professional following emerging innovation, or simply curious about how venture capital investment decisions are made, this session will offer insight into the work behind the investment.
All registrants will receive a recording of the webinar as well as a copy of our latest white paper by Mike Shufeldt titled Finding the Next Unicorn: How Venture Capital Firms Identify Billion-Dollar Potential in Early-Stage Companies.
Meet the Speakers
Chris Yoo, Ph.D. | Xcellerant Ventures
Chris Yoo is a molecular biologist, biotech entrepreneur, and investor with more than 25 years of experience across biotechnology, oncology, and artificial intelligence. He holds a Ph.D. in Cell and Molecular Biology from Yale University and brings deep expertise in healthcare and life sciences, including AI-driven drug discovery and translational medicine. His scientific and entrepreneurial background helps inform the evaluation of innovative technologies and their potential for real-world impact for Xcellerant Ventures.
Mike Shufeldt, MBA | Xcellerant Ventures
Mike Shufeldt, MBA is an entrepreneur and a reserve A-10 fighter pilot who brings a distinctive perspective on defense technology, execution, and leadership. His experience navigating complex, high-stakes environments informs his approach to evaluating businesses, assessing opportunities, and understanding what it takes for teams to execute successfully.
About the Jetstream Venture Fund
The Jetstream Venture Fund seeks to invest in companies building transformative technologies across artificial intelligence, biotechnology, and frontier innovation. The fund is designed to lower traditional barriers to venture capital participation while maintaining a broad investment approach across both private and public companies for semi-annual liquidity.
Disclosure:
Investors should consider the Fund’s investment objectives, risks, charges and expenses carefully before investing. The Fund’s prospectus contains this and additional information about the Fund, and can be obtained by emailing jetstream@sweaterfunds.com or by following this link. The Fund’s prospectus should be read carefully before investing. All investments involve risks, including possible loss of principal. Past performance of venture capital investments is no indication of future success.